Motif Bio Share Discussion Threads

[ny boy] 24/4/2017 15:55

Too good to miss, so I bought a chunk today. Also added to TCG

[blueblood] 24/4/2017 15:18

Once revive 2 funding is confirmed I also expect run up to £1 prior to further trial results.

[cudmore] 24/4/2017 14:37

£1 my short term target here

[someuwin] 24/4/2017 14:23

Well a $25 target in the US is a 150% rise from the current $10.

So a 150% rise here from 42p would take us up to 105p.

[jgoold] 24/4/2017 13:39

I bought these on the NASDAQ so looking forward to the open!

[blueblood] 24/4/2017 13:06

American broker just released increased price target from $16 to $25. Lets see the response from NASDAQ this pm..... happy days!

[banshee] 24/4/2017 12:34

The fund raising for completing Revive-2 may be small, but what about the fund raising for the new trial for ?lung infections? scheduled to start later this year? if I remember.

[mikeroot5] 24/4/2017 11:10

Trader Tim's thoughts:

Motif Bio, I think will head toward 50p before encountering some resistance. Longer term, the trend looks favourable for the drug company. One thing to watch for is the raising of funds to finalise Phase III testing. The placing for stage one of Phase III, amid the delayed, fumbled NASDAQ listing, hurt the share price. However, management will be raising cash from a much stronger position this time around, so I don’t expect this placing to derail share price momentum significantly.

hxxp://buff.ly/2oDfmLl

[loverat] 24/4/2017 11:00

This is one stock that folk buying in late Autumn last year had to be patient with. But few I think expected those levels to stay, even without news.

With news I look forward to this going above 60p relatively short term. I find overall it pays to bottom fish stocks - even if sometimes they take a while for sentiment to change.

GLA and well done to everyone who bought in the 20s and 30s. More to come I think.

[someuwin] 24/4/2017 10:25

With a successful Phase 3 now completed, this should get back to previous 70p levels quite quickly.

[cheshire man] 24/4/2017 09:37

Yes indeed someuwin :-)

[someuwin] 24/4/2017 08:09

Good start here.

[drmaccers] 23/4/2017 16:24

Looking forward to the week. A small pull back doesn't alter the overall trend. First stop the gap to 58

[panic investor] 21/4/2017 22:12

Not keen on all this proactive investor stuff as it's usually paid for - I hold though

[timbo003] 21/4/2017 17:54

New Proactiveinvestor interview: Phase III Iclaprim trial results 'bode very well' for Motif Bio, says Northland Capital's Alexandre (see active link below)


Contains some interesting commentary on peer group valuations

[someuwin] 21/4/2017 15:50

...longer term (18 months plus) it should move to several pounds.

[hjs] 21/4/2017 10:15

IMO, and this is not a recommendation...

The share price will run up to 60p and the company will announce another set of placing/offer of new shares at a discount to get more cash for Revive-2.

Longer term it should move to 100p.

[cudmore] 21/4/2017 09:05

£1 imho on next RNS

[toolsmoker] 21/4/2017 08:45

This has 60p written all over it

[cheshire man] 21/4/2017 08:29

Looking good this morning :-)

[pauliewonder] 21/4/2017 08:24

Ok will check them out when I'm on laptop. Thanks

[timbo003] 21/4/2017 08:16

>>pauliewonder

The links to the two interviews are in the header (at the bottom)

[pauliewonder] 21/4/2017 08:14

Can you post a link to the interview please? Must have missed it

[someuwin] 21/4/2017 08:03

Watched the interviews. This looks like a fantastic bargain now.

[cudmore] 20/4/2017 20:45

I can see this soaring to nearer £1 imho. The potential here is huge. Holding out for the ride!